Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D is a research paper published in JNCI Journal of the National Cancer Institute (2020). On theSindex it has a DataRank of 0.769. It has been cited 168 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.769
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Cancer Research UK
Grant: C12292/A20861
Cancer Research Society
Grant: OG-24377
Spanish Instituto de Salud Carlos III
Grant: PI19/00640
Spanish Health Research Foundation, Instituto de Salud Carlos III
Grant: INT15/00070
Spanish Health Research Foundation, Instituto de Salud Carlos III
Grant: INT16/00154
Spanish Health Research Foundation, Instituto de Salud Carlos III
Grant: INT17/00133
European Research Council
Grant: 310018
Investigating Hereditary Cancer Predisposition – a combined genomics approach
NCI NIH HHS
Grant: R01 CA225662
Cancer Research UK
Grant: C490/A10124
NCI NIH HHS
Grant: P50 CA116201
Cancer Research UK
Grant: 20861
Medical Research Council
Grant: MC_UU_12023/20
Cancer Research UK
Grant: C1005/A12677
Cancer Research UK
Grant: C490/A10119
Cancer Research UK
Grant: C490/A16561
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA178535
National Health and Medical Research Council (NHMRC)
Grant: 400281
Molecular Epidemiology of Ovarian Cancer: The Australian Ovarian Cancer Study National Clinical Follow-Up Core
National Institutes of Health
Grant: 5R01CA225662-05
The contribution of RAD51C and RAD51D to breast and ovarian cancer
National Health and Medical Research Council (NHMRC)
Grant: 400413
Australian Ovarian Cancer Study (AOCS): A multidisciplinary ovarian cancer resource for the genomic era
National Institutes of Health
Grant: 1R01CA178535-01
The contribution of rare alleles to ovarian cancer in the population
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1R01CA061107-01
RISK FACTORS AND PROGNOSTIC FACTORS FOR OVARIAN CANCER
European Commission
Grant: 634935
Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES)
National Health and Medical Research Council (NHMRC)
Grant: 199600
Towards cancer control: Population and molecular strategies
National Institutes of Health
Grant: 5P50CA116201-08
Career Development (Ingle)
NIHR Biomedical Research Centre at University College London Hospitals National Health Service Foundation Trust and University College London
FEDER
FWCI
16.82
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
Additional file 1 of Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
Additional file 3 of Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
Additional file 3 of Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
Additional file 1 of Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis
Additional file 1 of Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis
Additional file 2 of Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer
Additional file 2 of Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer